Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Testori

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Cancer|July 15, 1991
Comparison of long-term survival of 1986 consecutive patients with breast cancer treated at the National Cancer Institute of Milano, Italy (1971 to 1972 and 1977 to 1978)N Cascinelli, M Greco, A Morabito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2009
Utility of adjuvant systemic therapy in melanomaA M M Eggermont, A Testori, J Marsden, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2012
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study)C Lebbe, P Lorigan, P Ascierto, et al.
The American Journal of Surgical Pathology|June 1, 1992
Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parametersL Scopsi, S Andreola, S Pilotti, et al.
Melanoma Research|February 8, 2000
Sentinel node localization in primary melanoma: learning curve and resultsA Testori, M Bartolomei, C Grana, et al.
International Journal of Cancer|August 19, 1991
Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factorsF Rilke, M I Colnaghi, N Cascinelli, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of deviceR Biffi, F Corrado, F de Braud, et al.
British Journal of Cancer|January 8, 2009
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanomaA Rocca, S Minucci, G Tosti, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2015
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumabS Valpione, C Martinoli, P Fava, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 20, 2015
Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic PatientsF De Rose, L Cozzi, P Navarria, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Cancer|July 15, 1991
Comparison of long-term survival of 1986 consecutive patients with breast cancer treated at the National Cancer Institute of Milano, Italy (1971 to 1972 and 1977 to 1978)N Cascinelli, M Greco, A Morabito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2009
Utility of adjuvant systemic therapy in melanomaA M M Eggermont, A Testori, J Marsden, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2012
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study)C Lebbe, P Lorigan, P Ascierto, et al.
The American Journal of Surgical Pathology|June 1, 1992
Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parametersL Scopsi, S Andreola, S Pilotti, et al.
Melanoma Research|February 8, 2000
Sentinel node localization in primary melanoma: learning curve and resultsA Testori, M Bartolomei, C Grana, et al.
International Journal of Cancer|August 19, 1991
Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factorsF Rilke, M I Colnaghi, N Cascinelli, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of deviceR Biffi, F Corrado, F de Braud, et al.
British Journal of Cancer|January 8, 2009
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanomaA Rocca, S Minucci, G Tosti, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2015
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumabS Valpione, C Martinoli, P Fava, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 20, 2015
Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic PatientsF De Rose, L Cozzi, P Navarria, et al.
Pageof 8